JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Net Income
JW (Cayman) Therapeutics Co Ltd
Net Income Peer Comparison
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Net Income
-¥768m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Income
-¥1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Net Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Net Income?
Net Income
-768m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Net Income amounts to -768m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
-23%
Over the last year, the Net Income growth was 9%. The average annual Net Income growth rates for JW (Cayman) Therapeutics Co Ltd have been 23% over the past three years , -23% over the past five years .